Pharmaceutical and biopharmaceutical companies are still being hit by the Global recession.  The consolidation process is continuing but will the new units operate more efficiently, and be more cost effective? 

We believe that the ‘cost of compliance’ is driven up by a lack of understanding of what compliance really means. A better understanding of engineering design can be used to question existing practices and find alternative ways of achieving regulatory compliance at a reduced cost.

This seminar will study the impact that engineering design has on the bottom line. There will also be discussion on the all-important topic of regulatory compliance requirements and the key issues it raises.  The seminar is a follow up to the successful Pharmaceutical Engineering Design for Compliance event held last year, the aim being to offer further advice and explore topics in greater detail.  Practical applications of materials and the relevant compliance issues will be highlighted. The seminar will look at contact materials and material finishes, as well as the effect on cleaning.